BENGALURU (Reuters) - India has approved the use of Russia's "Sputnik V" vaccine against COVID-19 based on strong immunogenicity data, the Economic Times newspaper reported on Monday.
It would be the third COVID-19 vaccine approved in India after AsztraZeneca's Covishield, and local firm Bharat Biotech's COVAXIN.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!